More on Caremark denying medication to a retiree
Subject: Fwd: Why was my approved prescription denied? (Part III) & an almost 2 month delay for notification by mail of denial
Memphis Business Journal - December 19, 2005
Medco said it will appeal the award.
The allegations made in the case were related to agreements the retirement system first signed in 1993, when Medco began providing pharmacy benefit services to the system's 430,000 retiriees and beneficiaries.
The Hamilton County, Ohio, jury handed down a decision against Medco related to non-contractual duties stemming from the business relationship bewteen Medco and STRS, according to a press release issued by Medco Monday.
STRS had accused Medco of pocketing $55 million in drug-maker rebates as well as charging $49 million in unwarranted prescription-dispensing fees from 1993 through 2001.
The Medco release said plaintiffs were seeking more than $300 million in damages, but the Hamilton County, Ohio jury rejected allegations that Medco breached its contract relating to mail-order dispensing fees. The jury was unable to reach a decision on whether Medco breached its contract related to a rebate-sharing agreement. In November, the judge in the case dismissed portions of the lawsuit due to lack of evidence.
Medco general counsel David Machlowitz said the evidence supported complete vindication for Medco.
"Although the award was a fraction of the claim made by the plaintiffs, we believe there are multiple grounds for Medco to successfully reverse this decision on appeal," Machlowitz said. "Medco's conduct was appropriate, legal, and professional, and in accord with our contract, which served the best interests of the state retirement system."
In a separate action, the jury cleared co-defendant Merck & Co. Inc. (NYSE:MRK), Medco's former parent company, of tortious interference.
Based in Franklin Lakes, N.J., Medco (NYSE: MHS) manages prescription drug benefit programs and operates a mail order and Internet pharmacy. In August it acquired Memphis-based Accredo Health Inc. for $2.2 billion to form the nation's largest specialty pharmacy.
<< Home